CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on May 7, 2009
Clinical Journal of the American Society of Nephrology
© 2009 American Society of Nephrology
doi: 10.2215/CJN.00800209
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Press Release
Right arrow All Versions of this Article:
CJN.00800209v1
4/6/1121    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moen, M. F.
Right arrow Articles by Fink, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moen, M. F.
Right arrow Articles by Fink, J. C.

Received February 4, 2009
Accepted on April 1, 2009

ORIGINAL ARTICLES

Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease

Maureen F. Moen *{dagger}, Min Zhan {dagger}, Van Doren Hsu {ddagger}, Lori D. Walker {ddagger}, Lisa M. Einhorn *{dagger}, Stephen L. Seliger *{dagger}, and Jeffrey C. Fink *{dagger}1

Departments of *Medicine and {dagger}Epidemiology and Preventive Medicine, School of Medicine, and {ddagger}Pharmaceutical Research Computing, School of Pharmacy, University of Maryland, Baltimore, Maryland


1 To whom correspondence should be addressed. E-mail: jfink{at}medicine.umaryland.edu.


   Abstract

Background and objectives: This study set out to determine the incidence of hypoglycemia in patients with chronic kidney disease (CKD), with and without diabetes, and the association of hypoglycemia with mortality.

Design, setting, participants, & measurements: This was a retrospective cohort analysis of 243,222 patients who had 2,040,206 glucose measurements and were cared for at the Veterans Health Administration. CKD was defined as an estimated GFR of <60 ml/min per 1.73 m2. Hypoglycemia was set at <70 mg/dl. Mortality was measured 1 day after glucose measurement.

Results: The incidence of hypoglycemia was higher in patients with CKD versus without CKD. Among patients with diabetes, the rate was 10.72 versus 5.33 per 100 patient-months and among patients without diabetes was 3.46 versus 2.23 per 100 patient-months, for CKD versus no CKD, respectively. The odds of 1-d mortality were increased at all levels of hypoglycemia but attenuated in CKD versus no CKD. Adjusted odds ratios for 1-d mortality that were associated with glucose values of <50, 50 to 59, and 60 to 69 mg/dl, respectively, versus glucose of ≥70 mg/dl were 6.09, 4.10, and 1.85 for inpatient records from patients with CKD; 9.95, 3.79, and 2.54 for inpatients records from patients without CKD; 6.84, 3.28, and 3.98 for outpatient records from patients with CKD; and 13.28, 7.36, and 4.34 for outpatient records from patients without CKD.

Conclusions: CKD is a risk for hypoglycemia, with or without diabetes. The excessive mortality associated with hypoglycemia makes this complication a significant threat to patient safety in CKD.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Society of Nephrology.